Patents expiring in 2028

US 7399823

Antimicrobial theta defensins and methods of using same

The Regents of the University of California · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7399759

1, 3-benzothiazinone derivatives and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7402595

JNK inhibitor

Takeda Pharmaceutical Company Limited · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7402659

Thymic stromal lymphopoietin receptor molecules and uses thereof

THE GOVERNMENT OF THE UNITED STATES OF AMERICA · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7402590

Spiroazacyclic compounds as monoamine receptor modulators

ACADIA Pharmaceuticals Inc. · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7402578

Methods for inhibiting cognitive deterioration in adults with down's syndrome

Corcept Therapeutics Incorporated · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7402299

Intracorporeal medicaments for photodynamic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7402673

Diamine β2 adrenergic receptor agonists

Theravance, Inc. · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7402567

Treatment of disease by inducing cell apoptosis

The United States of America as represented by the Department of Veterans Affairs, Office of the General Counsel (024) · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7404961

Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7405199

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7405202

CRISP polypeptides as contraceptives and inhibitors of sperm capacitation

Regents of the University of Minnesota · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7404956

Immunoglobulin chimeric monomer-dimer hybrids

Syntonix Pharmaceuticals, Inc. · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7405233

Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

PTC THERAPEUTICS, INC. · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7405266

Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof

Nektar Therapeutics AL, Corporation · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7405302

5-lipoxygenase-activating protein (FLAP) inhibitors

AMIRA PHARMACEUTICALS, INC. · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7405286

Stars—A muscle-specific actin-binding protein

The Board of Regents of the University of Texas System · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7405287

Method of treating a cancer

The Board of Regents of the University of Texas System · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7405314

Compounds and methods for the treatment of cancer

The Board of Regents of the University of Texas System · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7404954

Methods of targeting agents to cells expressing the polymeric immunoglobulin receptor

The Regents of the University of California · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7405041

Methods for regulating transcription by targeting quadruplex DNA

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7407939

Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics

CureGenics Ltd. · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7407964

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7408075

Synthesis of phosphocholine ester derivatives and conjugates thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7407962

Heteroaryl compounds useful as inhibitors or protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7407664

Peptide vaccines against group A streptococci

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7407658

Vaccines for blocking transmission of plasmodium vivax

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7407656

PSCA: prostate stem cell antigen and uses thereof

The Regents of the University of California · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7407976

Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7407935

Ricin toxin A-chain fragment for use as a vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410958

Triterpene quaternary salts as biologically active surfactants

Regents of the University of Minnesota · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410363

Electrical connector having compliant biasing device

Hon Hai Precision Ind. Co., Ltd. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410641

Antibodies to insulin/IGF/relaxin family polypeptides

Takeda Pharmaceutical Company Limited · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410665

Coated implantable medical device

Cook Regentec LLC · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410758

Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN

The Board of Regents of the University of Texas System · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410644

Recombinant pox virus for immunization against tumor-associated antigens

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410771

Reagent and method for detecting a Cryptosporidium parvum sporozoite antigen

The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410776

Polypeptides, their production and use

Takeda Pharmaceutical Company Limited · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410950

Peptides of CaV2.2 that inhibit pain

The Board of Regents of the University of Texas System · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410979

Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410978

Once daily dosage forms of trospium

Supernus Pharmaceuticals, Inc. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7411067

Crystalline forms of gatifloxacin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410781

IL-4/IL-13 specific polypeptides and therapeutic uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410956

Caspase inhibitor prodrugs

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7410981

Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers

Takeda Pharmaceutical Company Limited · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7411076

Coumarin derivative

Institute of Medicinal Molecular Design, Inc. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7413870

SAK: modulation of cellular proliferation for treatment of cancer

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7414039

Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis

The Regents of the University of California · Granted Tue Aug 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)